Clinical Trials Office
Clinical Trials Office
批准号:
7714242
负责人:
HOWARD S HOCHSTER
金额:
$10.28万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-18 至 2013-02-28
关键词:
AppointmentBudgetsCancer CenterClinicalClinical InvestigatorClinical ResearchClinical TrialsClosureConduct Clinical TrialsCritiquesDataData AnalysesData CollectionDevelopmentDiscipline of NursingEnsureEnvironmentFunding AgencyGoalsGrowthGuidelinesInstitutesInstitutionMalignant NeoplasmsMedicalMedical centerMeta-AnalysisModelingNumbersOutcomeProceduresProcessProtocols documentationQuality ControlReportingResearchResearch Ethics CommitteesResearch PersonnelResourcesServicesStandards of Weights and MeasuresTherapy Clinical TrialsTimeTranslatinganticancer researchconceptdata managementimprovedinterdisciplinary collaborationmedical schoolsnovelprogramsprotocol developmentquality assuranceresponsesuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Clinical Trials Office (CTO) provides administrative, research and educational services to the Cancer
Institute investigators and research staff conducting clinical trials. It serves as the main coordinating center
for cancer-related clinical trials from concept development and submission to closure including protocol
development, regulatory and compliance guidance, administrative submissions, data collection and data
management, data analysis, and quality control functions, and serves as the administrative interface to other
clinical research organizations at the NYU Medical Center. The goals of this resource are to:
Facilitate clinical trials by providing a framework for development, submission, and conduct of dinical
trials.
Enhance and facilitate data collection and reporting of clinical cancer research data.
Provide educational programs for the CTO staff and clinical investigators.
Promote interdisciplinary collaboration and a venue for translating research findings to the clinical arena
In response to the previous critique, internal audits, and the review of external consultants, significant
changes have occurred within the CTO since the last review. These changes include the appointment of
new medical and administrative directors, new standard operating procedures, and restructuring of data
management. These improvements have produced a CTO that better meets the needs of investigators
performs more effectively within the NYU School of Medicine clinical research environment. Currently, the
CTO supervises 49 research staff and manages 158 open protocols. The CTO continues to expand and
improve its function to serve as the central coordinating center for the clinical research enterprise at the
NYUCI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Yale Cancer Center NCTN
-
批准号:8839216
-
项目类别:
-
资助金额:$55.15万
-
财政年份:2014
-
负责人:HOWARD S HOCHSTER
-
依托单位:
CLINICAL TRIAL: CETUXIMAB PLUS CAPECITABINE AND OXALIPLATIN FOR METASTATIC COLOR
-
批准号:7718426
-
项目类别:
-
资助金额:$0.77万
-
财政年份:2008
-
负责人:HOWARD S HOCHSTER
-
依托单位:
CLINICAL TRIAL: ALIMTA AND GEMZAR IN ADVANCED PANCREATIC AND BILIARY TRACT CANCE
-
批准号:7718420
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2008
-
负责人:HOWARD S HOCHSTER
-
依托单位:
ALIMTA AND GEMZAR IN ADVANCED PANCREATIC AND BILIARY TRACT CANCER
-
批准号:7605733
-
项目类别:
-
资助金额:$2.33万
-
财政年份:2007
-
负责人:HOWARD S HOCHSTER
-
依托单位:
OXALIPLATIN (ELOXATIN) WITH BORTEZOMIB IN PATIENTS WITH ADVANCED MALIGNANCY
-
批准号:7605716
-
项目类别:
-
资助金额:$0.99万
-
财政年份:2007
-
负责人:HOWARD S HOCHSTER
-
依托单位:
ECOG N0147: OXAL PLUS 5-FU/CF W/WO CETUXIMAB IN STAGE III COLON CANCERECOG N0
-
批准号:7605775
-
项目类别:
-
资助金额:$0.95万
-
财政年份:2007
-
负责人:HOWARD S HOCHSTER
-
依托单位:
BEVACIZUMAB/CETUXIMAB/IRINOTECAN OR BEVACIZUMAB/CETUXIMAB IN COLORECTAL CANCER
-
批准号:7378324
-
项目类别:
-
资助金额:$2.24万
-
财政年份:2006
-
负责人:HOWARD S HOCHSTER
-
依托单位:
ALIMTA AND GEMZAR IN ADVANCED PANCREATIC AND BILIARY TRACT CANCER
-
批准号:7378319
-
项目类别:
-
资助金额:$7.58万
-
财政年份:2006
-
负责人:HOWARD S HOCHSTER
-
依托单位:
CETUXIMAB PLUS CAPECITABINE AND OXALIPLATIN FOR METASTATIC COLORECTAL CANCER
-
批准号:7378335
-
项目类别:
-
资助金额:$2.34万
-
财政年份:2006
-
负责人:HOWARD S HOCHSTER
-
依托单位:
OXALIPLATIN (ELOXATIN) WITH BORTEZOMIB IN PATIENTS WITH ADVANCED MALIGNANCY
-
批准号:7378298
-
项目类别:
-
资助金额:$2.95万
-
财政年份:2006
-
负责人:HOWARD S HOCHSTER
-
依托单位:
Pharmacodynamics of Gemcitabine by MRS in Pancreatic CA
-
批准号:6988335
-
项目类别:
-
资助金额:$43.09万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
THE FARNESYL TRANSFERASE INHIBITOR R115777 IN COMBINATION WITH TOPOTECAN
-
批准号:7207064
-
项目类别:
-
资助金额:$0.24万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
ALIMTA AND GEMZAR IN ADVANCED PANCREATIC AND BILIARY TRACT CANCER
-
批准号:7207168
-
项目类别:
-
资助金额:$1.67万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
N9831: DOXORUBICIN/CYCLOPHOSPHAMIDE/TAXOL +OR -TRASTUZUMAB FOR BREAST CANCER
-
批准号:7207067
-
项目类别:
-
资助金额:$2.63万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
Pharmacodynamics of Gemcitabine by MRS in Pancreatic CA
-
批准号:7409167
-
项目类别:
-
资助金额:$42.2万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
Pharmacodynamics of Gemcitabine by MRS in Pancreatic CA
-
批准号:7089043
-
项目类别:
-
资助金额:$49.98万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
OXALIPLATIN (ELOXATIN) WITH BORTEZOMIB IN PATIENTS WITH ADVANCED MALIGNANCY
-
批准号:7207141
-
项目类别:
-
资助金额:$3.15万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
BEVACIZUMAB/CETUXIMAB/IRINOTECAN OR BEVACIZUMAB/CETUXIMAB IN COLORECTAL CANCER
-
批准号:7207173
-
项目类别:
-
资助金额:$0.48万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
Pharmacodynamics of Gemcitabine by MRS in Pancreatic CA
-
批准号:7226213
-
项目类别:
-
资助金额:$41.38万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
ECOG E3201: PHASE III STUDY IN PATIENTS WITH STAGE II OR III RECTAL CANCER
-
批准号:7207162
-
项目类别:
-
资助金额:$1.67万
-
财政年份:2005
-
负责人:HOWARD S HOCHSTER
-
依托单位:
海外基金